Alyeska Investment Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$875K	–	557
2022 Q2	$875K	Buy	+50,000	New	+$875K	0.01%	502